Metabolic Mechanisms, Emerging Therapeutic Targets, and Advances in Drug Research for Dyslipidemia
Dyslipidemia is a metabolic condition characterized by abnormal plasma lipid or lipoprotein levels. Persistently elevated LDL-C, triglyceride-rich lipoproteins and their remnants, and lipoprotein(a) [Lp(a)] can all promote atherosclerotic cardiovascular disease. In addition to traditional ...
危险品化学品经营许可证（带存储）